Literature DB >> 16741630

Present treatment of acute myocardial infarction in patients over 75 years--data from the Berlin Myocardial Infarction Registry (BHIR).

Jochen Schuler1, Birga Maier, Steffen Behrens, Walter Thimme.   

Abstract

AIMS: Guidelines issued by European and German cardiology societies clearly define procedures for treatment of acute myocardial infarction (AMI). These guidelines, however, are based on clinical studies in which older patients are underrepresented. Older patients, on the other hand, represent a large and growing portion of the infarction population. It was our goal in the present paper to analyse the present treatment of AMI patients over 75 years of age in the city of Berlin, Germany, with data gained from the Berlin Myocardial Infarction Registry (BHIR).
METHODS: We prospectively collected data from 5079 patients (3311 men and 1768 women, mean age 65.6) with acute myocardial infarction who were treated in 25 hospitals in Berlin during the period 1999-2003. 1319 patients (25.9%) were older than 75 (mean age 82.5 years).
RESULTS: Overall hospital mortality rate was 11.6%. In patients over 75, this rate was 23.9%; among the younger infarction population, it was 7.3%. In contrast to the younger AMI patients, the majority of those over 75 were female (62.5 vs 25.1% for the younger) and demonstrated a significantly higher frequency of all prognostically meaningful comorbidities (heart failure 14.4% vs. 3.5%; renal failure 11.5 vs 3.9%; diabetes 37.3 vs 24.3%). Clinical signs of severe infarction, moreover, were more common among the aged patients (pulmonary congestion 45.4 vs 19.7%; left bundle branch block 12.7 vs 3.6%). Pre-hospital time was prolonged (2.8 vs 2 h) and guideline-recommended therapy was applied significantly less frequently to AMI patients over 75 (reperfusion therapy 39.8 vs 71.7%, beta-blockers 62.8 vs 78.3%, statins 26.5 vs 45.5%). Multivariate analysis revealed the following factors to be independent predictors of hospital mortality in patients over 75: age (OR 1.05 per year), acute heart failure (OR 2.39), pre-hospital resuscitation (OR 10.6), cardiogenic shock (OR 2.73), pre-hospital delay >12 h (OR 1.68), and ST elevation in the first ECG (OR 2.09). Independent predictors of a favourable hospital course were as follows: admission to a hospital >600 beds (OR 0.64), reperfusion therapy (OR 0.63), early betablocker treatment (OR 0.46), and early application of ACE inhibitors (OR 0.48).
CONCLUSION: Infarction patients over 75 have a very high hospital complication and mortality rate. They are typically treated with delay, and with less adherence to relevant guidelines than are younger patients. Reperfusion therapy, early administration of beta-blockers and ACE inhibitors, as well as admission to large medical centres are all factors that contribute to a favourable prognosis of high-aged AMI patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16741630     DOI: 10.1007/s00392-006-0393-8

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  25 in total

1.  In-hospital mortality of elderly patients with acute myocardial infarction: data from the MITRA (Maximal Individual Therapy in Acute Myocardial Infarction) registry.

Authors:  K K Haase; R Schiele; S Wagner; F Fischer; U Burczyk; R Zahn; S Schuster; J Senges
Journal:  Clin Cardiol       Date:  2000-11       Impact factor: 2.882

2.  [Acute myocardial infarction in Germany between 1996 and 1998: therapy and intrahospital course. Results of the Myocardial Infarction Registry (MIR) in Germany].

Authors:  S Wagner; S Schneider; R Schiele; F Fischer; H Dehn; R Grube; G Becker; B Baumgärtel; E Altmann; J Senges
Journal:  Z Kardiol       Date:  1999-10

3.  Comparison of cardiac findings at necropsy in octogenarians, nonagenarians, and centenarians.

Authors:  W C Roberts; J Shirani
Journal:  Am J Cardiol       Date:  1998-09-01       Impact factor: 2.778

4.  Representation of elderly persons and women in published randomized trials of acute coronary syndromes.

Authors:  P Y Lee; K P Alexander; B G Hammill; S K Pasquali; E D Peterson
Journal:  JAMA       Date:  2001-08-08       Impact factor: 56.272

5.  Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3.

Authors:  W J Rogers; J G Canto; C T Lambrew; A J Tiefenbrunn; B Kinkaid; D A Shoultz; P D Frederick; N Every
Journal:  J Am Coll Cardiol       Date:  2000-12       Impact factor: 24.094

6.  Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

Authors:  J S Hochman; L A Sleeper; J G Webb; T A Sanborn; H D White; J D Talley; C E Buller; A K Jacobs; J N Slater; J Col; S M McKinlay; T H LeJemtel
Journal:  N Engl J Med       Date:  1999-08-26       Impact factor: 91.245

7.  Emotional attitudes toward symptoms and inadequate coping strategies are major determinants of patient delay in acute myocardial infarction.

Authors:  M Kentsch; U Rodemerk; G Müller-Esch; U Schnoor; T Münzel; T H Ittel; R Mitusch
Journal:  Z Kardiol       Date:  2002-02

8.  The effect of dementia on outcomes and process of care for Medicare beneficiaries admitted with acute myocardial infarction.

Authors:  Frank A Sloan; Justin G Trogdon; Lesley H Curtis; Kevin A Schulman
Journal:  J Am Geriatr Soc       Date:  2004-02       Impact factor: 5.562

9.  Reduced collateral circulation to the infarct-related artery in elderly patients with acute myocardial infarction.

Authors:  Toshiya Kurotobi; Hiroshi Sato; Kunihiro Kinjo; Daisaku Nakatani; Hiroya Mizuno; Masahiko Shimizu; Katsuji Imai; Atsushi Hirayama; Kazuhisa Kodama; Masatsugu Hori
Journal:  J Am Coll Cardiol       Date:  2004-07-07       Impact factor: 24.094

10.  Primary angioplasty with routine stenting compared with thrombolytic therapy in elderly patients with acute myocardial infarction.

Authors:  Ilan Goldenberg; Shlomi Matetzky; Amir Halkin; Arie Roth; Elio Di Segni; Dov Freimark; Dan Elian; Oren Agranat; Yedael Har Zahav; Victor Guetta; Hanoch Hod
Journal:  Am Heart J       Date:  2003-05       Impact factor: 4.749

View more
  15 in total

1.  Clinical trial updates and hotline sessions presented at the Scientific Session 2007 of the American Heart Association.

Authors:  U Laufs; H Nef; H Möllmann; F Custodis; M Böhm
Journal:  Clin Res Cardiol       Date:  2007-12-18       Impact factor: 5.460

2.  Encouraging trends in acute myocardial infarction survival in the oldest old.

Authors:  Jennifer Tjia; Jeroan Allison; Jane S Saczynski; Mayra Tisminetzky; Jane L Givens; Kate Lapane; Darleen Lessard; Robert J Goldberg
Journal:  Am J Med       Date:  2013-07-05       Impact factor: 4.965

Review 3.  Ivabradine in Patients with Stable Coronary Artery Disease: A Rationale for Use in Addition to and Beyond Percutaneous Coronary Intervention.

Authors:  Cosmo Godino; Antonio Colombo; Alberto Margonato
Journal:  Clin Drug Investig       Date:  2017-02       Impact factor: 2.859

4.  Ivabradine for the treatment of stable angina pectoris in octogenarians.

Authors:  Ralf Koester; Jan Kaehler; Thomas Meinertz
Journal:  Clin Res Cardiol       Date:  2010-09-06       Impact factor: 5.460

5.  Mortality following myocardial infarction in women and men: an analysis of insurance claims data from inpatient hospitalizations.

Authors:  Günther Heller; Birgit Babitsch; Christian Günster; Martin Möckel
Journal:  Dtsch Arztebl Int       Date:  2008-04-11       Impact factor: 5.594

6.  The initial slope of the VCO2/VO2-curve (s1) in cardiopulmonary exercise testing is a strong and independent predictor of outcome in patients with previous myocardial infarction.

Authors:  Joerg Honold; Lenka Geiger; Birgit Assmus; Ulrich Fischer-Rasokat; Volker Schaechinger; Andreas M Zeiher; Ioakim Spyridopoulos
Journal:  Clin Res Cardiol       Date:  2008-08-11       Impact factor: 5.460

7.  Lipoprotein-associated phospholipase A2 for early risk stratification in patients with suspected acute coronary syndrome: a multi-marker approach: the North Wuerttemberg and Berlin Infarction Study-II (NOBIS-II).

Authors:  M Möckel; R Müller; J O Vollert; C Müller; O Danne; R Gareis; T Störk; R Dietz; W Koenig
Journal:  Clin Res Cardiol       Date:  2007-06-27       Impact factor: 5.460

8.  Proinflammatory cytokines in acute myocardial infarction with and without cardiogenic shock.

Authors:  Marianne Debrunner; Ernst Schuiki; Elisabeth Minder; Edwin Straumann; Barbara Naegeli; Raymond Mury; Osmund Bertel; Jürgen Frielingsdorf
Journal:  Clin Res Cardiol       Date:  2007-12-28       Impact factor: 5.460

9.  Risk predictors for adverse outcomes after percutaneous coronary interventions and their related costs.

Authors:  Michele Pohlen; Holger Bunzemeier; Wibke Husemann; Norbert Roeder; Günter Breithardt; Holger Reinecke
Journal:  Clin Res Cardiol       Date:  2008-03-03       Impact factor: 5.460

10.  Mortality after emergency department intubation.

Authors:  Leon D Sanchez; J Scott Goudie; Jennifer De la Pena; Kevin Ban; Jonathan Fisher
Journal:  Int J Emerg Med       Date:  2008-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.